Rituximab for Immune Hemolytic Anemia following T- and B-Cell-Depleted Hematopoietic Stem Cell Transplantation

Publisher： Karger

E-ISSN： 1421-9662|109|1|43-45

ISSN： 0001-5792

Source： Acta Haematologica, Vol.109, Iss.1, 2002-12, pp. : 43-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 259-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post‐first and post‐second hematopoietic stem cell transplant

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 391-398

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-02 ,pp. : 110-113

Karger

Access to resources Recommend Favorite

Expansion of CD56-Negative, CD16-Positive, KIR-Expressing Natural Killer Cells after T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-03 ,pp. : 13-20

Karger

Access to resources Recommend Favorite

Hepatic Veno-Occlusive Disease following Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 106, Iss. 1-2, 2001-09 ,pp. : 57-68

Karger

Access to resources Recommend Favorite